Skip to main content

Table 3 Procedural data

From: Left atrial appendage morphology, echocardiographic characterization, procedural data and in-hospital outcome of patients receiving left atrial appendage occlusion device implantation: a prospective observational study

 

Watchman

ACP 2

All

p Value

Success rate, n (%)

21 (95.5)

15 (100)

36 (97.3)

0.403

Complete ostial occlusion (i.e., gap < 5 mm), n (%)

20 (90.9)

14 (93.3)

34 (91.9)

0.791

Positioning attempts, n (IQR)

2.5 (1.75–3)

2 (1.5–5)

2 (2–3)

0.555

Changes of device size, n (IQR)

1 (1–1)

1 (1–2)

1 (1–1)

0.169

Final device size, mm (IQR)

24 (21–27)

25 (22–30)

24 (22–27)

-

Duration, min. (IQR)

122.5 (75–136.25)

100 (80–110)

110 (76–135)

0.069

Fluoroscopy time, min. (IQR)

11.7 (7.4–16.8)

12.7 (9.5–17.7)

12.4 (8.5–16.9)

0.244

Reference dose, Gy*cm2 (IQR)

80.5 (45.75–103.25)

62 (52–89)

64 (49–96)

0.842

Amount of contrast agent, ml (IQR)

165 (130–202.25)

140 (110–180)

157 (110–195)

0.833

LAA configuration, n (%)

    

 - Chicken-wing

14 (63.6)

11 (73.3)

25 (67.6)

0.536

 - Windsock

3 (13.6)

1 (6.7)

4 (10.8)

0.503

 - Broccoli

4 (18.2)

3 (20)

7 (18.9)

0.890

 - Tub

1 (4.5)

0 (0)

1 (2.7)

0.403

Number of lobi, n (%)

    

 - 1

4 (18.2)

3 (20)

7 (18.9)

0.890

 - 2

13 (59.1)

10 (66.7)

23 (62.2)

0.641

 - 3

1 (4.5)

0 (0)

1 (2.7)

0.403

 - Multi

4 (18.2)

2 (13.3)

6 (16.2)

0.694

Days on ICU/IMC, n (IQR)

1 (1–1)

1 (1–1)

1 (1–1)

0.327

Post-procedural days in hospital, n (IQR)

3 (2.25–4)

4 (2.75–5.25)

4 (2.75–5)

0.341

  1. Values are given as medians (25th and 75th percentiles) or total numbers (percentage). ICU intensive care unit, IMC intermediate care unit